- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.80 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.5: 2 residues within 4Å:- Chain A: A.706, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.14: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.25: 3 residues within 4Å:- Chain C: A.706, E.1072, N.1074
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.6: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.7: 1 residues within 4Å:- Chain A: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.15: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.16: 1 residues within 4Å:- Chain B: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.26: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.27: 1 residues within 4Å:- Chain C: N.1134
No protein-ligand interaction detected (PLIP)- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.29: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: K.147, N.149, M.153
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain A: T.108, N.234, T.236
- Chain C: K.462, E.465
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: N.280, N.282
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: N.343, V.367, S.373, F.374
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain A: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain A: N.1158
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: K.147, N.149, M.153
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: E.132, N.164, N.165
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.234
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.331, Q.580, T.581
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1158
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: Y.28, T.29, N.61
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: K.147, N.149, M.153
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.343
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain C: N.709
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1158
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
- Release Date
- 2021-11-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.80 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
- Release Date
- 2021-11-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C